(Schedules of Concentration of Risk) (Details)	6 Months Ended		12 Months Ended
	Dec. 30, 2022	Jun. 16, 2022	Dec. 30, 2022	Dec. 31, 2021	Dec. 25, 2020
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | CuraScript, Inc [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		15.60%		26.10%	27.40%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | FFF Enterprises, Inc.
Concentration Risk [Line Items]
Concentration risk, percentage	26.10%	11.80%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | CuraScript, Inc [Member]
Concentration Risk [Line Items]
Concentration risk, percentage				12.70%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			17.30%	15.00%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			23.30%	30.00%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | FFF Enterprises, Inc.
Concentration Risk [Line Items]
Concentration risk, percentage			16.20%
Product Concentration Risk | Net Sales Attributable to Products | Acthar Gel (1)
Concentration Risk [Line Items]
Concentration risk, percentage	28.30%	25.40%		26.90%	27.90%
Product Concentration Risk | Net Sales Attributable to Products | Inomax
Concentration Risk [Line Items]
Concentration risk, percentage	16.70%	19.00%		20.30%	20.90%
Product Concentration Risk | Net Sales Attributable to Products | Ofirmev [Member]
Concentration Risk [Line Items]
Concentration risk, percentage					10.10%
Product Concentration Risk | Net Sales Attributable to Products | Therakos
Concentration Risk [Line Items]
Concentration risk, percentage	12.50%	12.50%		12.10%
Product Concentration Risk | Net Sales Attributable to Products | APAP
Concentration Risk [Line Items]
Concentration risk, percentage	10.70%	11.00%